The association between weight at birth and breast cancer risk revisited using Mendelian randomisation
Standard
The association between weight at birth and breast cancer risk revisited using Mendelian randomisation. / Kar, Siddhartha P; Andrulis, Irene L; Brenner, Hermann; Burgess, Stephen; Chang-Claude, Jenny; Considine, Daniel; Dörk, Thilo; Evans, Dafydd Gareth R; Gago-Domínguez, Manuela; Giles, Graham G; Hartman, Mikael; Huo, Dezheng; Kaaks, Rudolf; Li, Jingmei; Lophatananon, Artitaya; Margolin, Sara; Milne, Roger L; Muir, Kenneth R; Olsson, Håkan; Punie, Kevin; Radice, Paolo; Simard, Jacques; Tamimi, Rulla M; Van Nieuwenhuysen, Els; Wendt, Camilla; Zheng, Wei; Pharoah, Paul D P.
in: EUR J EPIDEMIOL, Jahrgang 34, Nr. 6, 06.2019, S. 591-600.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The association between weight at birth and breast cancer risk revisited using Mendelian randomisation
AU - Kar, Siddhartha P
AU - Andrulis, Irene L
AU - Brenner, Hermann
AU - Burgess, Stephen
AU - Chang-Claude, Jenny
AU - Considine, Daniel
AU - Dörk, Thilo
AU - Evans, Dafydd Gareth R
AU - Gago-Domínguez, Manuela
AU - Giles, Graham G
AU - Hartman, Mikael
AU - Huo, Dezheng
AU - Kaaks, Rudolf
AU - Li, Jingmei
AU - Lophatananon, Artitaya
AU - Margolin, Sara
AU - Milne, Roger L
AU - Muir, Kenneth R
AU - Olsson, Håkan
AU - Punie, Kevin
AU - Radice, Paolo
AU - Simard, Jacques
AU - Tamimi, Rulla M
AU - Van Nieuwenhuysen, Els
AU - Wendt, Camilla
AU - Zheng, Wei
AU - Pharoah, Paul D P
PY - 2019/6
Y1 - 2019/6
N2 - Observational studies suggest that higher birth weight (BW) is associated with increased risk of breast cancer in adult life. We conducted a two-sample Mendelian randomisation (MR) study to assess whether this association is causal. Sixty independent single nucleotide polymorphisms (SNPs) known to be associated at P < 5 × 10-8 with BW were used to construct (1) a 41-SNP instrumental variable (IV) for univariable MR after removing SNPs with pleiotropic associations with other breast cancer risk factors and (2) a 49-SNP IV for multivariable MR after filtering SNPs for data availability. BW predicted by the 41-SNP IV was not associated with overall breast cancer risk in inverse-variance weighted (IVW) univariable MR analysis of genetic association data from 122,977 breast cancer cases and 105,974 controls (odds ratio = 0.86 per 500 g higher BW; 95% confidence interval 0.73-1.01). Sensitivity analyses using four alternative methods and three alternative IVs, including an IV with 59 of the 60 BW-associated SNPs, yielded similar results. Multivariable MR adjusting for the effects of the 49-SNP IV on birth length, adult height, adult body mass index, age at menarche, and age at menopause using IVW and MR-Egger methods provided estimates consistent with univariable analyses. Results were also similar when all analyses were repeated after restricting to estrogen receptor-positive or -negative breast cancer cases. Point estimates of the odds ratios from most analyses performed indicated an inverse relationship between genetically-predicted BW and breast cancer, but we are unable to rule out an association between the non-genetically-determined component of BW and breast cancer. Thus, genetically-predicted higher BW was not associated with an increased risk of breast cancer in adult life in our MR study.
AB - Observational studies suggest that higher birth weight (BW) is associated with increased risk of breast cancer in adult life. We conducted a two-sample Mendelian randomisation (MR) study to assess whether this association is causal. Sixty independent single nucleotide polymorphisms (SNPs) known to be associated at P < 5 × 10-8 with BW were used to construct (1) a 41-SNP instrumental variable (IV) for univariable MR after removing SNPs with pleiotropic associations with other breast cancer risk factors and (2) a 49-SNP IV for multivariable MR after filtering SNPs for data availability. BW predicted by the 41-SNP IV was not associated with overall breast cancer risk in inverse-variance weighted (IVW) univariable MR analysis of genetic association data from 122,977 breast cancer cases and 105,974 controls (odds ratio = 0.86 per 500 g higher BW; 95% confidence interval 0.73-1.01). Sensitivity analyses using four alternative methods and three alternative IVs, including an IV with 59 of the 60 BW-associated SNPs, yielded similar results. Multivariable MR adjusting for the effects of the 49-SNP IV on birth length, adult height, adult body mass index, age at menarche, and age at menopause using IVW and MR-Egger methods provided estimates consistent with univariable analyses. Results were also similar when all analyses were repeated after restricting to estrogen receptor-positive or -negative breast cancer cases. Point estimates of the odds ratios from most analyses performed indicated an inverse relationship between genetically-predicted BW and breast cancer, but we are unable to rule out an association between the non-genetically-determined component of BW and breast cancer. Thus, genetically-predicted higher BW was not associated with an increased risk of breast cancer in adult life in our MR study.
KW - Birth Weight/genetics
KW - Breast Neoplasms/epidemiology
KW - Female
KW - Humans
KW - Mendelian Randomization Analysis
KW - Polymorphism, Single Nucleotide
KW - Risk Assessment
U2 - 10.1007/s10654-019-00485-7
DO - 10.1007/s10654-019-00485-7
M3 - SCORING: Journal article
C2 - 30737679
VL - 34
SP - 591
EP - 600
JO - EUR J EPIDEMIOL
JF - EUR J EPIDEMIOL
SN - 0393-2990
IS - 6
ER -